(Q36052971)

11 August 2017

1 reference

title

Hypertension and atherosclerosis: clinical implications from the ALLHAT Trial (English)

1 reference

11 August 2017

John B Standridge

1

1 reference

11 August 2017

publication date

1 March 2005

1 reference

Current Atherosclerosis Reports

11 August 2017

published in

1 reference

11 August 2017

volume

7

1 reference

11 August 2017

issue

2

1 reference

11 August 2017

page(s)

132-139

1 reference

Molecular bases of the acute coronary syndromes

11 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11883-005-0036-Y

ALLHAT, or the soft science of the secondary end point

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11883-005-0036-Y

Predictors of an increased risk of future hypertension in Utah. A screening analysis

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11883-005-0036-Y

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

21 January 2018

1 reference

12 December 2020

Serum uric acid and plasma norepinephrine concentrations predict subsequent weight gain and blood pressure elevation

1 reference

12 December 2020

Microalbuminuria reduction with valsartan in patients with type 2 diabetes mellitus: a blood pressure-independent effect

1 reference

12 December 2020

Effect of the renin--angiotensin system on the vessel wall: using ACE inhibition to improve endothelial function

1 reference

12 December 2020

A family physician questions the conclusions from ALLHAT.

1 reference

12 December 2020

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

1 reference

12 December 2020

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

1 reference

12 December 2020

Managing high-risk patients with hypertension: focus on the renin-angiotensin system

1 reference

12 December 2020

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

1 reference

12 December 2020

Acute vascular effects of the angiotensin II receptor antagonist olmesartan in normal subjects: relation to the renin-aldosterone system

1 reference

12 December 2020

Serum uric acid and hypertension: the Olivetti heart study.

1 reference

12 December 2020

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

1 reference

12 December 2020

Serum uric acid and risk for development of hypertension and impaired fasting glucose or Type II diabetes in Japanese male office workers

1 reference

12 December 2020

Serum uric acid and the risk for hypertension and Type 2 diabetes in Japanese men: The Osaka Health Survey

1 reference

12 December 2020

Adverse prognostic significance of new diabetes in treated hypertensive subjects

1 reference

12 December 2020

Renal function in the elderly: results from the European Working Party on High Blood Pressure in the Elderly trial

1 reference

12 December 2020

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

1 reference

12 December 2020

Precursors of essential hypertension: pulmonary function, heart rate, uric acid, serum cholesterol, and other serum chemistries

1 reference

12 December 2020

Prevalence of high blood pressure and elevated serum creatinine level in the United States: findings from the third National Health and Nutrition Examination Survey (1988-1994).

1 reference

12 December 2020

A comparison of outcomes with angiotensin-converting--enzyme inhibitors and diuretics for hypertension in the elderly.

1 reference

12 December 2020

Hydrochlorothiazide exacerbates nitric oxide-blockade nephrosclerosis with glomerular hypertension in spontaneously hypertensive rats.

1 reference

12 December 2020

Influence of long-term, low-dose, diuretic-based, antihypertensive therapy on glucose, lipid, uric acid, and potassium levels in older men and women with isolated systolic hypertension: The Systolic Hypertension in the Elderly Program. SHEP Cooperat

1 reference

12 December 2020

Endothelial cell dysfunction and abnormal tissue perfusion

1 reference

12 December 2020

Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension

1 reference

12 December 2020

Hydrochlorothiazide Increases Efferent Glomerular Arteriolar Resistance in Spontaneously Hypertensive Rats

1 reference

12 December 2020

Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial

1 reference

12 December 2020

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

1 reference

12 December 2020

Pathophysiology of hypertension and endothelial dysfunction in patients with diabetes mellitus

1 reference

12 December 2020

Why we can't translate clinical trials into clinical practice in hypertension

1 reference

12 December 2020

Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial

1 reference

12 December 2020

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

1 reference

12 December 2020

Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2.

1 reference

12 December 2020

Calcium-channel blockers and the progression of renal disease

1 reference

12 December 2020

Deleterious effects of calcium channel blockade on pressure transmission and glomerular injury in rat remnant kidneys

1 reference

12 December 2020

Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis

1 reference

12 December 2020

Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria

1 reference

12 December 2020

Relevance of the plasma renin hormonal control system that regulates blood pressure and sodium balance for correctly treating hypertension and for evaluating ALLHAT

1 reference

12 December 2020

Hyperuricemia in primary and renal hypertension

1 reference

12 December 2020

Rationale and design of the avoiding cardiovascular events through combination therapy in patients living with systolic hypertension (ACCOMPLISH) trial: the first randomized controlled trial to compare the clinical outcome effects of first-line comb

1 reference

12 December 2020

Chymase is upregulated in diabetic nephropathy: implications for an alternative pathway of angiotensin II-mediated diabetic renal and vascular disease

1 reference

12 December 2020

ALLHAT: the largest and most important clinical trial in hypertension ever done in the USA. Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial

1 reference

12 December 2020

10.1007/S11883-005-0036-Y

Identifiers

DOI

1 reference

11 August 2017

1 reference